세계의 유착 방지 제품 시장 규모 조사 : 제품 유형별, 제품 형태별, 용도별, 최종사용자별, 지역별 예측(2022-2032년)

Global Anti-Adhesion Products market is valued at approximately USD 1.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.45% over the forecast period 2024-2032. Anti-adhesion products are specialized medical devices or substances designed to prevent the formation of adhesions, which are bands of scar tissue that abnormally bind two areas of tissue or organs together. These products are commonly utilized in surgeries to minimize postoperative complications, facilitate recovery, and reduce the likelihood of reoperation due to adhesions. They function by creating a physical barrier between tissues and organs or promoting more favorable healing environments to prevent the adhesion formation process. The global rise in the number of surgical interventions, particularly in fields such as gynecology, abdominal, pelvic, and cardiovascular surgeries, has significantly propelled the need for anti-adhesion products. Enhanced awareness among healthcare professionals about the implications of adhesions and the expansion of clinics and hospitals that provide surgical services have augmented the demand for these products. However, the application of anti-adhesion products requires precise techniques, and differences in surgical practices across regions and among individual surgeons can impact the standardization and consistency of their use. Furthermore, some anti-adhesion products have shown limited efficacy in various clinical settings or pose potential safety concerns, affecting their widespread utilization. Key players have invested in developing more effective, safer, and easier-to-use anti-adhesion products through dedicated research and innovation, addressing gaps in current offerings. Strategic collaborations between manufacturers, healthcare institutions, and research organizations can drive the advancement and dissemination of anti-adhesion technologies.

Natural adhesion barriers, derived from biological substances, are designed to mimic or enhance the body's natural barriers to adhesion formation. These products, consisting of proteins such as fibrin or collagen, are intrinsic to the human healing process and can be resorbed by the body over time. Their biocompatibility and ability to integrate with the body's healing processes make them a favored choice for many surgical applications, particularly those involving delicate tissues. Collagen and protein-based adhesion barriers, primarily derived from bovine or porcine sources, function by creating a physical barrier between tissues during the healing process, preventing them from adhering to each other. Fibrin adhesion barriers leverage the natural clotting mechanism of blood, supporting tissue regeneration while preventing adhesion formation. Synthetic adhesion barriers, crafted from man-made materials, prevent tissue adhesion without integrating into the body's natural healing processes. Hyaluronic acid (HA) adhesion barriers, synthetic biocompatible materials, prevent tissue adhesion with minimal immune response. Polyethylene glycol (PEG)-based products provide a physical separation between tissues, allowing independent healing and minimizing adhesion formation. Regenerated cellulose barriers, biodegradable and turning into a gel absorbed by the body over time, facilitate use without necessitating removal.

Film formulations are increasingly preferred due to their ease of application and precision in placement. Anti-adhesion films are thin, biodegradable layers applied directly to tissues during surgical procedures, acting as a physical barrier to prevent tissue adhesion. Gel formulations, viscous semi-solid substances, conform to irregular surfaces and spaces, providing a flexible barrier that reduces or prevents adhesion. Liquid formulations, designed for application to surgical sites where they solidify or gelatinize, offer ease of application, particularly in procedures with limited access or visibility.

Cardiovascular surgeries use anti-adhesion products to prevent adhesions that could impede heart tissue movement or obstruct cardiovascular function post-surgery. General or abdominal surgeries, prone to adhesion development within the abdominal cavity, use anti-adhesion products to minimize these risks, facilitating smoother postoperative recovery. Gynecological surgeries, including procedures on the uterus, ovaries, and fallopian tubes, use anti-adhesion products to prevent adhesions that can lead to infertility, pelvic pain, and other complications. Neurological surgeries, though less common, use anti-adhesion products to prevent adhesions affecting nervous system components. Orthopedic surgeries, particularly those involving tendon or ligament repair, use anti-adhesion products to prevent tissue adhesions restricting joint mobility or causing pain post-procedure. Reconstructive surgeries, especially those involving skin grafts or tissue flaps, use anti-adhesion products to prevent adhesions compromising aesthetic and functional outcomes. Urological surgeries use anti-adhesion products to prevent adhesions impacting urinary function or fertility.

Hospitals and clinics extensively use anti-adhesion products across a broad spectrum of surgical interventions. In ambulatory surgical centers, anti-adhesion products facilitate rapid healing and reduce complications leading to readmissions, particularly in laparoscopic, gynecological, and general surgeries.

The key regions considered for the global Anti-Adhesion Products market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Anti-Adhesion Products market in terms of revenue. The market growth in the region is being attributed to factors including the presence of sophisticated healthcare systems, large numbers of surgical procedures, and high patient awareness. The region is home to ongoing research and development that produces creative solutions. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by extensive healthcare reforms, rising healthcare spending, and rising public awareness of the advantages of modern surgical procedures. Also, rising research and development initiatives coupled with an emphasis on producing economical and effective solutions are further propelling the market demand across the region.

Major market players included in this report are:

• Johnson & Johnson Services, Inc.
• Baxter International Inc.
• Medtronic PLC
• Integra LifeSciences Holdings Corporation
• Anika Therapeutics, Inc.
• FzioMed, Inc.
• Betatech Medical
• BioCer Entwicklungs-GmbH
• Lifecore Biomedical, Inc.
• Innocoll Holdings Public Limited
• SEIKAGAKU CORPORATION
• KLAS Medical Ltd.
• Leader Biomedical Europe B.V.
• Olympus Corporation
• Pfizer Inc.

The detailed segments and sub-segment of the market are explained below:

By Product Type:

• Natural Adhesion Barriers
• Synthetic Adhesion Barriers

By Product Form:

• Film Formulation
• Gel Formulation
• Liquid Formulation

By Application:

• Cardiovascular Surgeries
• General/Abdominal Surgeries
• Gynecological Surgeries
• Neurological Surgeries
• Orthopedic Surgeries
• Reconstructive Surgeries
• Urological Surgeries

By End-User:

• Ambulatory Surgical Centers
• Hospitals & Clinics

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Anti-Adhesion Products Market Executive Summary

• 1.1. Global Anti-Adhesion Products Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product Type
  • 1.3.2. By Product Form
  • 1.3.3. By Application
  • 1.3.4. By End-User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Anti-Adhesion Products Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Anti-Adhesion Products Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Surgical Interventions
  • 3.1.2. Innovation in Anti-Adhesion Products
  • 3.1.3. Enhanced Awareness Among Healthcare Professionals
• 3.2. Market Challenges
  • 3.2.1. Variability in Surgical Techniques
  • 3.2.2. Limited Efficacy and Safety Concerns
• 3.3. Market Opportunities
  • 3.3.1. Strategic Collaborations and Research Initiatives
  • 3.3.2. Adoption of New Materials and Technologies

Chapter 4. Global Anti-Adhesion Products Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Anti-Adhesion Products Market Size & Forecasts by Product Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Anti-Adhesion Products Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Natural Adhesion Barriers
  • 5.2.2. Synthetic Adhesion Barriers

Chapter 6. Global Anti-Adhesion Products Market Size & Forecasts by Product Form 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Anti-Adhesion Products Market: Product Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Film Formulation
  • 6.2.2. Gel Formulation
  • 6.2.3. Liquid Formulation

Chapter 7. Global Anti-Adhesion Products Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Anti-Adhesion Products Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Cardiovascular Surgeries
  • 7.2.2. General/Abdominal Surgeries
  • 7.2.3. Gynecological Surgeries
  • 7.2.4. Neurological Surgeries
  • 7.2.5. Orthopedic Surgeries
  • 7.2.6. Reconstructive Surgeries
  • 7.2.7. Urological Surgeries

Chapter 8. Global Anti-Adhesion Products Market Size & Forecasts by End-User 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Anti-Adhesion Products Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 8.2.1. Ambulatory Surgical Centers
  • 8.2.2. Hospitals & Clinics

Chapter 9. Global Anti-Adhesion Products Market Size & Forecasts by Region 2022-2032

• 9.1. North America Anti-Adhesion Products Market
  • 9.1.1. U.S. Anti-Adhesion Products Market
    • 9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
    • 9.1.1.2. Product Form breakdown size & forecasts, 2022-2032
    • 9.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 9.1.1.4. End-User breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Anti-Adhesion Products Market
• 9.2. Europe Anti-Adhesion Products Market
  • 9.2.1. UK Anti-Adhesion Products Market
  • 9.2.2. Germany Anti-Adhesion Products Market
  • 9.2.3. France Anti-Adhesion Products Market
  • 9.2.4. Spain Anti-Adhesion Products Market
  • 9.2.5. Italy Anti-Adhesion Products Market
  • 9.2.6. Rest of Europe Anti-Adhesion Products Market
• 9.3. Asia-Pacific Anti-Adhesion Products Market
  • 9.3.1. China Anti-Adhesion Products Market
  • 9.3.2. India Anti-Adhesion Products Market
  • 9.3.3. Japan Anti-Adhesion Products Market
  • 9.3.4. Australia Anti-Adhesion Products Market
  • 9.3.5. South Korea Anti-Adhesion Products Market
  • 9.3.6. Rest of Asia Pacific Anti-Adhesion Products Market
• 9.4. Latin America Anti-Adhesion Products Market
  • 9.4.1. Brazil Anti-Adhesion Products Market
  • 9.4.2. Mexico Anti-Adhesion Products Market
  • 9.4.3. Rest of Latin America Anti-Adhesion Products Market
• 9.5. Middle East & Africa Anti-Adhesion Products Market
  • 9.5.1. Saudi Arabia Anti-Adhesion Products Market
  • 9.5.2. South Africa Anti-Adhesion Products Market
  • 9.5.3. Rest of Middle East & Africa Anti-Adhesion Products Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Johnson & Johnson Services, Inc.
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. Baxter International Inc.
  • 10.3.3. Medtronic PLC
  • 10.3.4. Integra LifeSciences Holdings Corporation
  • 10.3.5. Anika Therapeutics, Inc.
  • 10.3.6. FzioMed, Inc
  • 10.3.7. Betatech Medical
  • 10.3.8. BioCer Entwicklungs-GmbH
  • 10.3.9. Lifecore Biomedical, Inc.
  • 10.3.10. Innocoll Holdings Public Limited
  • 10.3.11. SEIKAGAKU CORPORATION
  • 10.3.12. KLAS Medical Ltd.
  • 10.3.13. Leader Biomedical Europe B.V.
  • 10.3.14. Olympus Corporation
  • 10.3.15. Pfizer Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes